Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul;13(7):1857-1858.
doi: 10.1007/s13346-023-01352-5. Epub 2023 Apr 20.

Emerging immunotherapeutics for immune activation and tolerance

Affiliations
Editorial

Emerging immunotherapeutics for immune activation and tolerance

Ryan M Pearson et al. Drug Deliv Transl Res. 2023 Jul.
No abstract available

PubMed Disclaimer

References

    1. Thumsi A, Swaminathan SJ, Mangal JL, Suresh AP, Acharya AP. Vaccines prevent reinduction of rheumatoid arthritis symptoms in collagen-induced arthritis mouse model. Drug Deliv Transl Res. 2023. 10.1007/s13346-023-01333-8. - DOI - PMC - PubMed
    1. Jarai BM, Bomb K, Fromen CA. Nanoparticle pre-treatment for enhancing the survival and activation of pulmonary macrophage transplant. Drug Deliv Transl Res. 2023. 10.1007/s13346-023-01319-6. - DOI - PMC - PubMed
    1. Fernandez-Marino I, Anfray C, Crecente-Campo J, Maeda A, Ummarino A, Teijeiro-Valino C, Blanco-Martinez D, Mpambani F, Poul L, Devalliere J, Germain M, Correa J, Fernandez-Villamarin M, Allavena P, Fernandez-Megia E, Alonso MJ, Andon FT. Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages. Drug Deliv Transl Res. 2022. 10.1007/s13346-022-01265-9. - DOI - PMC - PubMed
    1. McBride DA, Dorn NC, Yao M, Johnson WT, Wang W, Bottini N, Shah NJ. Short-chain fatty acid-mediated epigenetic modulation of inflammatory T cells in vitro. Drug Deliv Transl Res. 2022. 10.1007/s13346-022-01284-6. - DOI - PMC - PubMed
    1. Walters AA, Ali A, Wang JT, Al-Jamal KT. Anti-tumor antibody isotype response can be modified with locally administered immunoadjuvants. Drug Deliv Transl Res. 2022. 10.1007/s13346-022-01258-8. - DOI - PMC - PubMed

Publication types

LinkOut - more resources